Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5 + Stem Cells via Inhibition of Wnt and Notch Signaling
Journal
Cellular and Molecular Gastroenterology and Hepatology
Journal Volume
7
Journal Issue
2
Pages
255-274
Date Issued
2019
Author(s)
Zha J.-M.
Li H.-S.
Lin Q.
Jiang Z.-H.
Tsai P.-Y.
Ding N.
Wu J.
Xu S.-F.
Wang Y.-T.
Pan J.
Zhou X.-M.
Chen K.
Tao M.
Odenwald M.A.
Tamura A.
Tsukita S.
Turner J.R.
He W.-Q.
Abstract
BACKGROUND & AIMS: Epithelial regeneration is essential for homeostasis and repair of the mucosal barrier. In the context of infectious and immune-mediated intestinal disease, interleukin (IL) 22 is thought to augment these processes. We sought to define the mechanisms by which IL22 promotes mucosal healing. METHODS: Intestinal stem cell cultures and mice were treated with recombinant IL22. Cell proliferation, death, and differentiation were assessed in vitro and in vivo by morphometric analysis, quantitative reverse transcriptase polymerase chain reaction, and immunohistochemistry. RESULTS: stem cells, or increased epithelial proliferation. IL22 induced stem cell apoptosis but, conversely, enhanced proliferation within and expanded numbers of transit-amplifying cells. These changes were associated with reduced wnt and notch signaling, both in vitro and in vivo, as well as skewing of epithelial differentiation, with increases in Paneth cells and reduced numbers of enteroendocrine cells. CONCLUSIONS: stem cell survival by inhibiting notch and wnt signaling. IL22 can therefore promote or inhibit mucosal repair, depending on whether effects on transit-amplifying or stem cells predominate. These data may explain why mucosal healing is difficult to achieve in some inflammatory bowel disease patients despite markedly elevated IL22 production.
SDGs
Publisher
Elsevier Inc
Type
journal article